The budding and depth of invasion model in oral cancer: A systematic review and meta-analysis
- PMID: 33031610
- DOI: 10.1111/odi.13671
The budding and depth of invasion model in oral cancer: A systematic review and meta-analysis
Abstract
Background: Tumour budding (B) and depth of invasion (D) have both been reported as promising prognostic markers in oral squamous cell carcinoma (OSCC). This meta-analysis assessed the prognostic value of the tumour budding and depth of invasion combination (BD model) in OSCC.
Methods: Databases including Ovid MEDLINE, PubMed, Scopus and Web of Science were searched for articles that studied the BD model as a prognosticator in OSCC. PICO search strategy was "In OSCC patients, does BD model have a prognostic power?" We used the reporting recommendations for tumour marker prognostic studies (REMARK) criteria to evaluate the quality of studies eligible for systematic review and meta-analysis.
Results: Nine studies were relevant as they analysed the BD model for prognostication of OSCC. These studies used either haematoxylin and eosin (HE) or pan-cytokeratin (PCK)-stained resected sections of OSCC. Our meta-analysis showed a significant association of BD model with OSCC disease-free survival (hazard ratio = 2.02; 95% confidence interval = 1.44-2.85).
Conclusions: The BD model is a simple and reliable prognostic indicator for OSCC. Evaluation of the BD model from HE- or PCK-stained sections could facilitate individualized treatment planning for OSCC patients.
Keywords: BD model; depth of invasion; oral squamous cell carcinoma; prognostication; survival analysis; tumour budding.
© 2020 Wiley Periodicals LLC.
Similar articles
-
Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection.BMC Cancer. 2024 Dec 18;24(1):1517. doi: 10.1186/s12885-024-13317-z. BMC Cancer. 2024. PMID: 39696123 Free PMC article.
-
Tumour budding in oral squamous cell carcinoma: a meta-analysis.Br J Cancer. 2018 Feb 20;118(4):577-586. doi: 10.1038/bjc.2017.425. Epub 2017 Nov 30. Br J Cancer. 2018. PMID: 29190636 Free PMC article.
-
Tumor budding - A promising prognostic histopathological parameter in oral squamous cell carcinoma - A comparative immunohistochemical study.J Oral Maxillofac Pathol. 2020 Sep-Dec;24(3):587. doi: 10.4103/jomfp.JOMFP_74_20. Epub 2021 Jan 9. J Oral Maxillofac Pathol. 2020. PMID: 33967517 Free PMC article.
-
Tumour budding evaluated in biopsy specimens is a useful predictor of prognosis in patients with cN0 early stage oral squamous cell carcinoma.Histopathology. 2017 May;70(6):869-879. doi: 10.1111/his.13144. Epub 2017 Feb 16. Histopathology. 2017. PMID: 27926795
-
The Impact of Histopathological Features on the Prognosis of Oral Squamous Cell Carcinoma: A Comprehensive Review and Meta-Analysis.Front Oncol. 2021 Nov 10;11:784924. doi: 10.3389/fonc.2021.784924. eCollection 2021. Front Oncol. 2021. PMID: 34858861 Free PMC article.
Cited by
-
The Prognostic Role of Perineural Invasion for Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.Cancers (Basel). 2024 Jul 11;16(14):2514. doi: 10.3390/cancers16142514. Cancers (Basel). 2024. PMID: 39061154 Free PMC article. Review.
-
Tumor Budding Should Be in Oral Cavity Cancer Reporting: A Retrospective Cohort Study Based on Tumor Microenvironment.Cancers (Basel). 2023 Aug 1;15(15):3905. doi: 10.3390/cancers15153905. Cancers (Basel). 2023. PMID: 37568721 Free PMC article.
-
Invasion-Associated Reorganization of Laminin 332 in Oral Squamous Cell Carcinomas: The Role of the Laminin γ2 Chain in Tumor Biology, Diagnosis, and Therapy.Cancers (Basel). 2022 Oct 7;14(19):4903. doi: 10.3390/cancers14194903. Cancers (Basel). 2022. PMID: 36230826 Free PMC article. Review.
-
Loss of Caveolin-1 Expression in Tumor Cells is Associated with Increased Aggressiveness and Cell Invasion in Oral Squamous Cell Carcinoma.Head Neck Pathol. 2023 Sep;17(3):618-630. doi: 10.1007/s12105-023-01562-w. Epub 2023 May 26. Head Neck Pathol. 2023. PMID: 37233885 Free PMC article.
-
Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection.BMC Cancer. 2024 Dec 18;24(1):1517. doi: 10.1186/s12885-024-13317-z. BMC Cancer. 2024. PMID: 39696123 Free PMC article.
References
REFERENCES
-
- Almangush, A., Coletta, R. D., Bello, I. O., Bitu, C., Keski-Säntti, H., Mäkinen, L. K., Kauppila, J. H., Pukkila, M., Hagström, J., Laranne, J., Tommola, S., Soini, Y., Kosma, V.-M., Koivunen, P., Kowalski, L. P., Nieminen, P., Grénman, R., Leivo, I., & Salo, T. (2015). A simple novel prognostic model for early stage oral tongue cancer. International Journal of Oral and Maxillofacial Surgery, 44, 143-150. https://doi.org/10.1016/j.ijom.2014.10.004
-
- Almangush, A., Heikkinen, I., Bakhti, N., Mäkinen, L. K., Kauppila, J. H., Pukkila, M., Hagström, J., Laranne, J., Soini, Y., Kowalski, L. P., Grénman, R., Haglund, C., Mäkitie, A. A., Coletta, R. D., Leivo, I., & Salo, T. (2018). Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers. Histopathology, 72, 1128-1135. https://doi.org/10.1111/his.13481
-
- Almangush, A., Leivo, I., Siponen, M., Sundquist, E., Mroueh, R., Mäkitie, A. A., Soini, Y., Haglund, C., Nieminen, P., & Salo, T. (2018). Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies. Virchows Archiv, 472, 231-236. https://doi.org/10.1007/s00428-017-2212-1
-
- Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012). Reporting recommendations for tumor marker prognostic studies (REMARK): Explanation and elaboration. PLoS Med, 9, e1001216. https://doi.org/10.1371/journal.pmed.1001216
-
- Amin, M. B., Edge, S. B., Greene, F. L., Byrd, D. R., Brookland, R. K., Washington, M. K., & Meyer, L. R. (2017). AJCC Cancer Staging Manual, 8th ed. Springer International Publishing.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical